Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This study aimed to evaluate and compare the cost of illness in patients with treatment-resistant schizophrenia (TRS) during 3 months before starting clozapine and for the initial 3 months of treatment with clozapine.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Clin Psychopharmacol

Title: Journal of clinical psychopharmacology

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1533-712X

ISSN (Print): 0271-0749

Publication date (Electronic): December 22 2020

Volume: 41

Issue: 1

Affiliations

[1 ] From the Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Article

Publisher Item ID: 00004714-202101000-00009

DOI: 10.1097/JCP.0000000000001332

PubMed ID: 33347021

SO-VID: c1455b85-0e1e-4fda-b00e-f0248682c807

History

Data availability:

Comments

Comment on this article

scite_

Cited by 3

See all cited by